ESC 365 - Accumulating evidence for deleterious effects of digoxin in heart failure and atrial fibrillation: an updated meta-analysis

ESC Premium Access

Accumulating evidence for deleterious effects of digoxin in heart failure and atrial fibrillation: an updated meta-analysis

Session: Poster Session 3 - Chronic heart failure – Pathophysiology and mechanisms

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Associate Professor M. Vamos (Szeged, HU)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Associate Professor Mate Vamos

University of Szeged, Szeged (Hungary)

0 follower

11 more presentations in this session

Cell growth, survival, and differentiation signal transduction pathways in advanced failing myocardium (gender dependent differences).

Speaker: Professor P. Leszek (Warsaw, PL)

Effect of cardiovascular risk factors on left ventricular ejection fraction in HER2 positive breast cancer patients who were treated in adjuvant setting with trastuzumab

Speaker: Professor M. Deljanin Ilic (Niska Banja, RS)

Therapeutic validity and effectiveness of guideline-recommended medical therapy in acute heart failure patients on regular hemodialysis

Speaker: Doctor K. Mizobuchi (Tokyo, JP)

Cardioprotective potential of an SGLT2 inhibitor against doxorubicin-induced heart failure

Speaker: Assistant Professor S. Cho (Seoul, KR)

Sympathomimetic beta-1AR autoantibodies in patients after heart transplantation are associated with higher mitochondrial coupling efficiency

Speaker: Doctor J. Haschemi (Duesseldorf, DE)

Access the full session

Poster Session 3 - Chronic heart failure – Pathophysiology and mechanisms

Speakers: Associate Professor M. Vamos, Professor P. Leszek, Professor M. Deljanin Ilic, Doctor K. Mizobuchi, Assistant Professor S. Cho...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources